A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma | ||
| dc.conicet.organizacion | Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Universidad Austral | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Center For Biomedical Research | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas | |
| dc.conicet.organizacion | Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Center For Biomedical Research | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Center For Biomedical Research | |
| dc.conicet.organizacion | Center For Biomedical Research | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.conicet.organizacion | Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas | |
| dc.conicet.organizacion | Clinica Universitaria de Navarra | |
| dc.contributor.author | Sangro, B. | |
| dc.contributor.author | Mazzolini Rizzo, Guillermo Daniel | |
| dc.contributor.author | Ruiz, M. | |
| dc.contributor.author | Ruiz, J. | |
| dc.contributor.author | Quiroga, J. | |
| dc.contributor.author | Herrero, I. | |
| dc.contributor.author | Qian, C. | |
| dc.contributor.author | Benito, A. | |
| dc.contributor.author | Larrache, J. | |
| dc.contributor.author | Olagüe, C. | |
| dc.contributor.author | Boan, J. | |
| dc.contributor.author | Peñuelas, I. | |
| dc.contributor.author | Sádaba, B. | |
| dc.contributor.author | Prieto, J. | |
| dc.date.issued | 2010-12 | |
| dc.description.abstract | The aim of this phase I clinical trial was to assess the feasibility and safety of intratumoral administration of a first-generation adenoviral vector encoding herpes simplex virus thymidine kinase (HSV-TK) gene (Ad.TK) followed by systemic ganciclovir to patients with advanced hepatocellular carcinoma (HCC). Secondarily, we have analyzed its antitumor effect. Ten patients were enrolled in five dose-level cohorts that received from 10 10 to 2 × 10 12 viral particles (vp). Ad.TK was injected intratumorally and patients received up to three doses at 30-day intervals. Positron emission tomography was used to monitor TK gene expression. Ad.TK injection was feasible in 100% of cases. Treatment was well tolerated and dose-limiting toxicity was not achieved. Cumulative toxicity was not observed. Hepatic toxicity was absent even in cirrhotic patients. Fever, flu-like syndrome, pain at the injection site and pancytopenia were the most common side effects. No partial responses were observed and 60% of patients showed tumor stabilization of the injected lesion. Importantly, two patients who received the highest dose showed signs of intratumoral necrosis by imaging procedures. One of them achieved a sustained stabilization and survived for 26 months. In conclusion, Ad.TK can be safely administered by intratumoral injection to patients with HCC up to 2 × 10 12 vp per patient. | es |
| dc.description.fil | Fil: Sangro, B.. Clinica Universitaria de Navarra; España. Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas; España | |
| dc.description.fil | Fil: Mazzolini Rizzo, Guillermo Daniel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Ruiz, M.. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Ruiz, J.. Center For Biomedical Research; España | |
| dc.description.fil | Fil: Quiroga, J.. Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas; España. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Herrero, I.. Clinica Universitaria de Navarra; España. Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas; España | |
| dc.description.fil | Fil: Qian, C.. Center For Biomedical Research; España | |
| dc.description.fil | Fil: Benito, A.. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Larrache, J.. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Olagüe, C.. Center For Biomedical Research; España | |
| dc.description.fil | Fil: Boan, J.. Center For Biomedical Research; España | |
| dc.description.fil | Fil: Peñuelas, I.. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Sádaba, B.. Clinica Universitaria de Navarra; España | |
| dc.description.fil | Fil: Prieto, J.. Clinica Universitaria de Navarra; España. Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas; España | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Sangro, B.; Mazzolini Rizzo, Guillermo Daniel; Ruiz, M.; Ruiz, J.; Quiroga, J.; et al.; A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma; Nature Publishing Group; Cancer Gene Therapy; 17; 12; 12-2010; 837-843 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0929-1903 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/96178 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 12 | es |
| dc.journal.pagination | 837-843 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Cancer Gene Therapy | es |
| dc.journal.volume | 17 | es |
| dc.language.iso | eng | es |
| dc.publisher | Nature Publishing Group | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/cgt.2010.40 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/cgt201040 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Thymidine kinase | es |
| dc.subject | Hepatocellular carcinoma | es |
| dc.subject | Gene therapy | es |
| dc.subject | Phase I | es |
| dc.subject | Adenovirus | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.d002c624-b391-4eb8-90da-d74282716e95_A.pdf
- Tamaño:
- 357.08 KB
- Formato:
- Adobe Portable Document Format